Foxo SPAC Presentation Deck
COMMERCIALIZATION
Development plan
We are executing a three phase development plan for
the growth of our products and services.
FOXO INVESTOR DECK 2022 Page 33
NOW
Preparation
Complete proprietary epigenetic biomarker R&D
• Build technology stack to support operations
Acquire life insurance company: FOXO Life Insurance Company
B2B2C MODEL
Insurance platform
Capitalize company and begin selling life insurance products
Quickly expand life insurance products with carrier partner (MGA)
Adopt Saliva-based Underwriting into products (MGA)
Expand distribution with Independent Agents (MGA)
B2B MODEL
Services platform
• Sell saliva-based underwriting technology and consumer
engagement services to domestic and international insurance
carriersView entire presentation